Drug-Coated Balloon for the Treatment of Small Vessel Coronary Artery Disease - A Randomized Non-Inferiority Trial.
Drug-coated balloons
In-stent restenosis
Small vessel disease
Journal
Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683
Informations de publication
Date de publication:
25 01 2023
25 01 2023
Historique:
pubmed:
1
12
2022
medline:
28
1
2023
entrez:
30
11
2022
Statut:
ppublish
Résumé
Drug-coated balloons (DCB) have shown promising results for the treatment of in-stent restenosis (ISR) and small vessel disease (SVD). However, data comparing the treatment efficacy of different DCBs are limited.Methods and Results: AGENT Japan is a prospective randomized controlled trial that compares the Agent balloon coated with a low-dose formulation of paclitaxel (2 μg/mm Data from this study demonstrate good clinical outcomes with the Agent DCB when used to treat patients with SVD or ISR.
Sections du résumé
BACKGROUND
Drug-coated balloons (DCB) have shown promising results for the treatment of in-stent restenosis (ISR) and small vessel disease (SVD). However, data comparing the treatment efficacy of different DCBs are limited.Methods and Results: AGENT Japan is a prospective randomized controlled trial that compares the Agent balloon coated with a low-dose formulation of paclitaxel (2 μg/mm
CONCLUSIONS
Data from this study demonstrate good clinical outcomes with the Agent DCB when used to treat patients with SVD or ISR.
Identifiants
pubmed: 36450540
doi: 10.1253/circj.CJ-22-0584
doi:
Substances chimiques
Paclitaxel
P88XT4IS4D
Types de publication
Randomized Controlled Trial
Equivalence Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM